IGHE and asthma: Currently, we use a triplet of validated and fully standardised biomarkers to detect the Type 2-high inflammatory endotype in asthma patients—the absolute eosinophil count in the peripheral blood (AEC), a fraction of nitric oxide in the exhaled breath (FeNO), and the production of immunoglobulin E (IgE) [71,72].